Lupin Limited and Salix Pharmaceuticals on Friday announced that they have entered into a definitive distribution agreement under which Salix has granted Lupin the exclusive right to market, distribute and sell certain Salix products in Canada.
Salix Pharmaceuticals has completed its $2.6 billion acquisition of Santarus, Salix said.
Salix Pharmaceuticals will buy Santarus for $2.6 billion, the drug makers said.
Indian drug maker Lupin and U.S. drug maker Salix Pharmaceuticals announced Wednesday a licensing deal for technology related to a drug for traveler’s diarrhea.
The Food and Drug Administration declined to approve a drug made by Salix Pharmaceuticals for irritable bowel syndrome, Salix said Tuesday.
The U.S. Patent and Trademark Office has issued a patent to Salix Pharmaceuticals for a...